SCHEMBL1629072

SCHEMBL1629072

COc1cc(O)c(-c2ccnn2-c2ccccc2Cl)cc1S(=O)(=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.39
HTR6 P50406 1/20 0.39
NR3C2 P08235 2/20 0.38
KDM4E B2RXH2 2/20 0.36
GAA P10253 2/20 0.36
HTT P42858 1/20 0.36
SLC16A3 O15427 2/20 0.36
SLC16A1 P53985 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KCNN4 O15554 1/20 0.35
KDM5A P29375 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
NR1I2 O75469 2/20 0.35
RXRA P19793 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629125 0.87 HSP90AA1 (0.53) HSP90AA1SMN1; SMN2NR3C2GAASLC16A3
SCHEMBL1629197 0.85 ALPL (0.45) HSP90AA1ALDH1A1MAPT
SCHEMBL1630418 0.81 HSP90AA1 (0.41) HSP90AA1SMN1; SMN2NR3C2SLC16A3SLC16A1
SCHEMBL1628788 0.81 HSP90AA1 (0.41) HSP90AA1SMN1; SMN2NR3C2SLC16A3SLC16A1
SCHEMBL1219165 0.80 HSP90AA1 (0.40) HSP90AA1SMN1; SMN2NR3C2GAASLC16A3
SCHEMBL1631546 0.80 HSP90AA1 (0.40) HSP90AA1SMN1; SMN2NR3C2HTTSLC16A3
SCHEMBL1629171 0.79 HSP90AA1 (0.42) HSP90AA1SMN1; SMN2NR3C2KDM4EGAA
SCHEMBL1631450 0.79 HSP90AA1 (0.41) HSP90AA1SMN1; SMN2KDM4EHTTALDH1A1
SCHEMBL1629120 0.78 HSP90AA1 (0.47) HSP90AA1SMN1; SMN2NR3C2GAASLC16A3
SCHEMBL1631566 0.78 TSHR (0.44) HSP90AA1SMN1; SMN2NR3C2SLC16A3SLC16A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP claimed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US claimed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US claimed
EP-1776346-A1 1,5-DIPHENYLPYRAZOLES Merck Patent GmbH (DE) 2007-04-25 EP claimed
WO-2006018082-A1 1,5-DIPHENYLPYRAZOLES MERCK PATENT GMBH (DE) 2006-02-23 WO claimed
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885SMN1; SMN2 3103/4885HTR6 2005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.